Diabetes medications and bone. - Wikidata - wikimedia - TriplyDB

Diabetes medications and bone.

Diabetes medications and bone.

http://www.wikidata.org/entity/Q38272637

about

Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care.

P2860

Q36617758-651FE1FB-EEF2-4416-A069-307E19E53B89

P2860

Diabetes medications and bone.

http://www.wikidata.org/entity/Q38272637

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Diabetes medications and bone.

@en

type

label

Diabetes medications and bone.

@en

prefLabel

Diabetes medications and bone.

@en

P1433

Q38272637-F9D5ABC7-1484-4AFA-8442-D1522E456243

P1476

Q38272637-5E241C09-470E-4A18-AB3D-B3589EF80FFA

P2093

Q38272637-C1ABADA3-0A2E-4474-9EF7-F39DA0E6132F

P2860

Q38272637-0A1578E9-136C-4BD8-9A5A-65F1A9675E51

Q38272637-0A8D02EC-690B-4408-8F3E-409055FDF498

Q38272637-1265F553-61A4-4C45-B96D-2AA32F3FE614

Q38272637-16C40B64-12C8-4F18-8D28-95094EF8F6B1

Q38272637-2059327C-61EE-4A83-B966-A003E46D21C3

Q38272637-234F53A1-AD3C-4FBC-A975-E73B2F72BE75

Q38272637-23A15525-FCB3-4C32-A205-D276C3D20BFD

Q38272637-2803785B-4971-471D-8D02-91921BDCC589

Q38272637-3358AF8E-4720-468E-80DD-8B2A552A98A6

Q38272637-36A55874-954E-483B-93F8-0CB806599C72

P2888

Q38272637-354288B2-BE9C-454D-9EA2-0D652CB42542

P304

Q38272637-88C8C1EB-9181-4AB0-81BB-870A48DF1E7D

P31

Q38272637-68167D8B-6FA7-41AC-B75D-8D2F527598DD

P356

Q38272637-A2225833-4E72-4897-ADD2-DF525B81442E

P433

Q38272637-C097F564-647F-4673-95FE-50DAC084804A

P478

Q38272637-C73128D8-98FC-4D78-BDDE-99E20F62CE40

P577

Q38272637-A669F069-A4A9-4B1A-9D2F-C267AFE790A0

P6179

Q38272637-9347BEAB-1D6E-4BB5-9DCA-1AB7F22DC973

P698

Q38272637-8F7FCFDF-288B-41F1-82E8-40914D97B65E

P356

S11914-014-0250-Z

P1433

Current osteoporosis reports

P1476

Diabetes medications and bone.

@en

P2093

Andrew Grey

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study.

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes.

The murine glucagon-like peptide-1 receptor is essential for control of bone resorption.

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

P2888

s11914-014-0250-z

P304

35-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11914-014-0250-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015375551

http://www.w3.org/2001/XMLSchema#string

P698

25433437

http://www.w3.org/2001/XMLSchema#string